Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

Summary sheet

Release date
1 December 2023
Status
Reference
Approved | 05/03/2024
20220864
Project name
Promoter - financial intermediary
CLUJ MEDICINE & PHARMACY UNIVERSITY
UNIVERSITATEA DE MEDICINA SI FARMACIE IULIU HATIEGANU CLUJ-NAPOCA
Proposed EIB finance (Approximate amount)
Total cost (Approximate amount)
EUR 25 million
EUR 63 million
Location
Sector(s)
Description
Objectives

The project concerns the construction of a simulation, training and research centre at the University of Medicine and Pharmacy "Iuliu Hatieganu" (UMFIH) in Cluj-Napoca, Romania.

The aim is to provide additional financial resources to extend and improve both teaching and research activities. Therefore, the project meets various needs of the innovation system in Romania, most notably the supply of highly-skilled graduates in key economic and social sectors, as well as the provision of infrastructure for public research. The project is part of a long term modernisation programme of the University and is in line with EU public policy goals associated with Education and Training 2020 and Horizon 2020. It will also contribute to the European Higher Education Area and the European Research Area by enhancing teaching and learning environments and improving research facilities.

Environmental aspects
Procurement

The Directive 2011/92/EU amended by 2014/52/EU does not specifically mention the need for an environmental impact assessment (EIA) for buildings relating to education, but it may be that some sub-projects can be regarded as urban renewal projects (Annex II of the European Directive). This will be analysed in detail during the development of the studies. The possible impact on natural sites will be checked prior to the building permit authorisation request stage.

The promoter has to ensure that contracts for the implementation of the project have been/shall be tendered in accordance with the relevant applicable EU procurement legislation (Directive 2014/24/EU as well as Directive 89/665/EEC) as interpreted by the Court of Justice of the EU, with the publication of tender notices in the Official Journal of the EU, as and where required.

Milestone
Approved
5 March 2024
Related projects
Link to source

Disclaimer

Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

Documents

Environmental and Social Data Sheet (ESDS) - CLUJ MEDICINE & PHARMACY UNIVERSITY
Publication Date
12 Mar 2024
Document language
Main Topic
Lending
Document Number
191691230
Document Focus
Environmental Information
Project Number
20220864
Sector(s)
Regions
Countries
Publicly available
Download now

General enquiries and comments

The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

Media enquiries

Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

Complaints mechanism

Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

Zero tolerance against fraud and corruption

The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

Related publications